Study guide

SUD Science Essentials for CASAC

CASAC Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Screening, Assessment, and Engagement

1.1 CASAC Credential and Exam Map 1.2 Screening Tools and Intake 1.3 Biopsychosocial Assessment 1.4 Motivational Interviewing and Engagement 1.5 Co-Occurring Disorders and Risk

2 Treatment Planning, Collaboration, and Referral

Individualized Treatment Plans ASAM Placement Criteria Levels of Care and Matching Interdisciplinary Collaboration Referral Coordination and Continuity

3 Counseling Modalities

Individual Counseling Skills Group Counseling and Dynamics CBT and Relapse Prevention 12-Step Facilitation and MI Integration Family Systems and Support

4 Ethics and Professional Responsibilities

Confidentiality: 42 CFR Part 2 and HIPAA Boundaries and Dual Relationships Ethics Codes and Mandated Reporting Cultural Competence and Equity Professional Development and Supervision

5 Education, Documentation, and Continuing Care

Psychoeducation for Clients and Families Clinical Documentation Standards Recovery Support and Continuing Care SUD Science Essentials for CASAC Exam Strategy and Case Application

SUD Science Essentials for CASAC

Key Takeaways Explain This Topic AI

The disease model views addiction as a chronic, relapsing brain condition — not a moral failing

DSM-5-TR diagnoses substance use disorder on a severity continuum using 11 criteria (tolerance and withdrawal among them)

Dopamine drives the reward pathway; repeated use hijacks motivation and impulse control

Alcohol and benzodiazepine withdrawal can be life-threatening; opioid withdrawal is severe but rarely fatal alone

  • FDA-approved MOUD for opioid use disorder: methadone, buprenorphine, and naltrexone
  • Last updated: July 2026

Science Principles Every CASAC Candidate Needs

Although IC&RC lists Education, Documentation, and Continuing Care as its own domain, scientific principles of substance use appear throughout the CASAC item bank. Accurate psychoeducation and sound clinical judgment depend on the same facts the exam tests: neurobiology , diagnostic criteria , withdrawal , and evidence-based pharmacotherapy .

Models of Addiction

  • Model Core idea Counseling implication
  • Disease model Chronic, progressive brain disease Reduces stigma; long-term treatment
  • Biopsychosocial Biology + psychology + environment Comprehensive assessment
  • Behavioral / learning Reinforced patterns Skills training, contingency management
  • Moral model (outdated) Character weakness Not evidence-based — exam distractor

The disease model — addiction as a chronic, relapsing condition requiring treatment — is widely accepted in OASAS and IC&RC frameworks. It does not mean the person has zero agency; it explains why abstinence-only willpower often fails without support.

DSM-5-TR Substance Use Disorder

DSM-5-TR replaced separate "abuse" and "dependence" diagnoses with one substance use disorder rated mild (2–3 criteria), moderate (4–5), or severe (6+) . Eleven criteria include:

  • Hazardous use, social/interpersonal problems, neglected roles
  • Tolerance — needing more for the same effect
  • Withdrawal — symptoms when stopping (or using to avoid withdrawal)

Craving, failed attempts to cut down, time spent obtaining/using, physical/psychological problems, abandoned activities, continued use despite harm

Tolerance and withdrawal were hallmarks of old "dependence" — still critical exam facts even under the unified diagnosis.

Neurobiology: Reward Pathway

Dopamine is the neurotransmitter most associated with the brain's reward system . Natural rewards (food, social connection) release dopamine at baseline levels. Drugs of misuse can cause a surge far above normal, reinforcing drug-seeking over healthier rewards. With repeated use, the brain may produce less natural dopamine, driving craving and anhedonia in early recovery — a science fact counselors use to normalize post-acute withdrawal experiences.

Withdrawal by Substance Class

Class Withdrawal severity Exam highlight

Alcohol / CNS depressants (benzos) Can be life-threatening (seizures, delirium tremens ) Requires medically supervised detox

  • Opioids Very distressing (rhinorrhea, myalgias, GI upset) Rarely fatal alone; still needs support
  • Stimulants Crash, depression, fatigue Supportive care; watch for depression/suicide
  • Cannabis Irritability, sleep disturbance Uncomfortable, not typically deadly

Naloxone (Narcan) is an opioid antagonist — it displaces opioids from receptors to reverse respiratory depression in overdose. Effects last roughly 30–90 minutes ; re-sedation is possible with long-acting opioids.

Medications Counselors Must Know

Counselors do not prescribe, but they educate and support adherence :

  • Disorder FDA-approved medications (representative)
  • Opioid use disorder Methadone (full agonist), buprenorphine (partial agonist), naltrexone (antagonist)
  • Alcohol use disorder Disulfiram, acamprosate, naltrexone

Do not confuse naloxone (overdose rescue) with naltrexone (maintenance antagonist). Clonidine may ease symptoms but is not an FDA-approved MOUD.

Process Addictions and Co-Occurring Context

Process addictions (gambling disorder, etc.) involve compulsive behavior without a substance — still relevant to biopsychosocial formulation. Co-occurring mental health disorders are the norm, not the exception; science literacy supports integrated treatment language.

DSM-5 Severity in Practice

Severity guides level of care conversations:

  • Mild — outpatient may suffice with strong supports
  • Moderate — IOP or structured outpatient often indicated
  • Severe — residential or medically managed care may be needed, especially with withdrawal risk

Counselors do not assign DSM codes independently in all settings, but they must recognize criteria during assessment and education.

Co-Occurring Disorders and Integrated Care

Dual diagnosis , co-occurring disorders , and comorbidity all describe SUD plus mental health conditions. Integrated treatment addresses both simultaneously rather than demanding "28 days clean before psychiatric care." Untreated depression or PTSD undermines psychoeducation about relapse risk.

Alcohol Pharmacotherapy Basics

  • Medication Mechanism (simplified) Counselor role
  • Disulfiram Aversive reaction if alcohol consumed Stress adherence, avoid alcohol-containing products
  • Acamprosate Stabilizes neurochemistry post-acute withdrawal Support daily adherence

Naltrexone Reduces craving/reward from alcohol (and opioids in MOUD form) Monitor motivation; note opioid sensitivity rules for opioid patients

Stimulant and Cannabis Science Notes

Stimulant use disorders lack FDA-approved medications comparable to MOUD; treatment emphasizes behavioral therapies, contingency management, and addressing co-occurring ADHD or depression when present. Cannabis withdrawal exists (irritability, vivid dreams, sleep disruption) — counselors should not dismiss it as "not real addiction" on exams or in groups.

Fentanyl and Overdose Education

Given the opioid supply crisis, psychoeducation must cover fentanyl contamination , rapid overdose , and multiple naloxone doses . Counselors distribute or refer to community naloxone programs per state law and agency policy. Clients who use alone face elevated fatality risk — education should address never-use-alone agreements and buddy check-ins.

Teaching Science Without Jargon

Translate research into client language: "Your brain adapted to expect the drug's dopamine spike; recovery is retraining the reward system." That sentence is psychoeducation and exam-ready science — the overlap this chapter domain expects. When clients ask "Am I weak?" science-based education reframes the question toward treatable brain adaptation and recoverable skills .